JP2025502205A5 - - Google Patents
Info
- Publication number
- JP2025502205A5 JP2025502205A5 JP2024541803A JP2024541803A JP2025502205A5 JP 2025502205 A5 JP2025502205 A5 JP 2025502205A5 JP 2024541803 A JP2024541803 A JP 2024541803A JP 2024541803 A JP2024541803 A JP 2024541803A JP 2025502205 A5 JP2025502205 A5 JP 2025502205A5
- Authority
- JP
- Japan
- Prior art keywords
- cytokine
- designed
- cell
- optionally
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263298623P | 2022-01-11 | 2022-01-11 | |
| US63/298,623 | 2022-01-11 | ||
| US202363479178P | 2023-01-09 | 2023-01-09 | |
| US202363479177P | 2023-01-09 | 2023-01-09 | |
| US202363479176P | 2023-01-09 | 2023-01-09 | |
| US63/479,177 | 2023-01-09 | ||
| US63/479,176 | 2023-01-09 | ||
| US63/479,178 | 2023-01-09 | ||
| PCT/US2023/060508 WO2023137346A2 (en) | 2022-01-11 | 2023-01-11 | Designed cytokine compositions and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502205A JP2025502205A (ja) | 2025-01-24 |
| JP2025502205A5 true JP2025502205A5 (https=) | 2026-01-21 |
Family
ID=87279672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024541803A Pending JP2025502205A (ja) | 2022-01-11 | 2023-01-11 | 設計されたサイトカイン組成物および使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250223330A1 (https=) |
| EP (1) | EP4463469A4 (https=) |
| JP (1) | JP2025502205A (https=) |
| KR (1) | KR20240164594A (https=) |
| CN (1) | CN119053616A (https=) |
| AU (1) | AU2023208031A1 (https=) |
| CA (1) | CA3248134A1 (https=) |
| IL (1) | IL314226A (https=) |
| MX (1) | MX2024008642A (https=) |
| WO (1) | WO2023137346A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL325764A (en) * | 2023-07-13 | 2026-03-01 | Outpace Bio Inc | Designed compositions of interleukin-2 cytokine and methods of use |
| WO2025212606A1 (en) * | 2024-04-01 | 2025-10-09 | Bio-Techne Corporation | Synthetic il-2 polypeptides and conjugates, compositions, and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210025522A (ko) * | 2018-06-25 | 2021-03-09 | 유니버시티 오브 워싱톤 | 강력하고 선택적인 인터루킨 모방체의 드 노보 디자인 |
| MX2021000801A (es) * | 2018-07-24 | 2021-04-12 | BioNTech SE | Agonistas de il2. |
| CN118510795A (zh) * | 2022-01-07 | 2024-08-16 | 苏州克睿基因生物科技有限公司 | 新型白介素-2多肽 |
-
2023
- 2023-01-11 WO PCT/US2023/060508 patent/WO2023137346A2/en not_active Ceased
- 2023-01-11 MX MX2024008642A patent/MX2024008642A/es unknown
- 2023-01-11 IL IL314226A patent/IL314226A/en unknown
- 2023-01-11 KR KR1020247026696A patent/KR20240164594A/ko active Pending
- 2023-01-11 AU AU2023208031A patent/AU2023208031A1/en active Pending
- 2023-01-11 JP JP2024541803A patent/JP2025502205A/ja active Pending
- 2023-01-11 US US18/727,646 patent/US20250223330A1/en active Pending
- 2023-01-11 CA CA3248134A patent/CA3248134A1/en active Pending
- 2023-01-11 EP EP23740805.9A patent/EP4463469A4/en active Pending
- 2023-01-11 CN CN202380027065.2A patent/CN119053616A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240294664A1 (en) | Chimeric antigen receptors, compositions, and methods | |
| US20250296975A1 (en) | Engineered cells, t cell immune modulating antibodies and methods for using the same | |
| CN115850476B (zh) | 一种cll1抗体及其应用 | |
| CA3094996A1 (en) | Guidance and navigation control proteins and method of making and using thereof | |
| CA3031955A1 (en) | Immunomodulatory polypeptides and related compositions and methods | |
| JP2019531704A5 (https=) | ||
| JP2025502205A5 (https=) | ||
| US20240261405A1 (en) | Methods and compositions for treating autoimmune disease | |
| US20230348556A1 (en) | Artificial immunosurveillance chimeric antigen receptor and cells expressing the same | |
| JP2023528255A5 (https=) | ||
| CN104829725A (zh) | 一种双特异性抗体cd133×cd3的构建及应用 | |
| CA3150884A1 (en) | Immune synapse-stabilizing chimeric antigen receptor (car) t cell | |
| KR20210132668A (ko) | 인공 면역감시 키메라 항원 수용체(ai-car) 및 이를 발현하는 세포 | |
| JP2023548556A5 (https=) | ||
| CN115996733A (zh) | 用于免疫疗法的基因工程化γδT细胞 | |
| US20240016932A1 (en) | Chimeric antigen receptor | |
| RS64771B1 (sr) | Trispecifični i/ili trovalentni vezujući proteini | |
| JP7505784B2 (ja) | Ｇｄ２結合性分子 | |
| AU2021308078A1 (en) | Chimeric MyD88 receptors for redirecting immunosuppressive signaling and related compositions and methods | |
| CN119894930A (zh) | 一种双特异性抗体及其应用 | |
| WO2024032247A9 (zh) | 一种cll1抗体及其应用 | |
| JP2025527510A (ja) | リガンド誘導性の転写調節および膜近接シグナルトランスダクションを同時に生じさせる多重鎖合成受容体 | |
| CN118108845B (zh) | 一种靶向B7-H3的CAR-γδT细胞的制备方法及应用 | |
| KR20250043434A (ko) | 억제 키메라 수용체 아키텍처 | |
| CN118215678A (zh) | Cd137和pd-l1结合剂的组合剂量方案 |